| Comment Number: | 522418-05081 |
| Received: | 6/29/2006 3:52:40 PM |
| Organization: | Associate of Oasis Life Sciences Lacy, Washington USA |
| Commenter: | Richard Arneson |
| State: | CA |
| Subject: | Business Opportunity Rule |
| Title: | Notice of Proposed Rulemaking |
| CFR Citation: | 16 CFR Part 437 |
| No Attachments |
Comments:
While some may find the need to better regulate this area of commerce due to perhaps the misdeeds of a few, as proposed it will cause unnessary and needless delays and opportunities for the honest people in the marketing arena. I believe the points raised by the organizations that represent the mainstream, ethical marketers need to be carefully taken into consideration. As a consumer, and a marketer of health care products, I find the proposed 7 day waiting/preview period to be an unfair restriction and delay to my making a intelligent decision as to my healthcare decisions. Perhaps an option by the consumer to have "x" number of days to cancel or adjust the purchase after making their initial decision would make more sense. Putting obstacles in before the transaction penalizes the ethicial marketer and their consumers. More serious thought needs to be given to this important aspect of direct marketing. Granted, the best of intentions are behind the new proposals, but as we know the path to you know where is paved with good intentions. Please step back and take a closer look at the proposals. We surely can do a much better job and protect the consumer at the same time. Richard Arneson Redding, Ca.